Back to Results
First PageMeta Content
Alcohols / Drug rehabilitation / Ketones / Euphoriants / Buprenorphine / Drug Addiction Treatment Act / Opioid dependence / Methadone / Naloxone / Chemistry / Organic chemistry / Morphinans


MICHIGAN DEPARTMENT OF COMMUNITY HEALTH OFFICE OF DRUG CONTROL POLICY TREATMENT POLICY # 03 SUBJECT: Buprenorphine ISSUED: August 2004, revised June 6, 2006 EFFECTIVE: September 1, 2004, revision effective October 1, 200
Add to Reading List

Document Date: 2013-05-31 13:56:36

Open Document

File Size: 219,65 KB

Share Result on Facebook

City

Washington / DC / Washington / D.C. / /

Company

CA. / /

Event

Product Issues / FDA Phase / Product Recall / /

Facility

Wayne State University / University Psychiatric Clinic / /

IndustryTerm

treatment services / clients receiving substance abuse services / /

MedicalCondition

sudden and intense withdrawal symptoms / Opiate Addiction / Opiate Dependence / respiratory depression / Statistical Manual ofMental Disorders / ofSubstance-Related Disorders / /

MedicalTreatment

adjunctive therapy / counseling / /

Organization

American Psychiatric Association / office of Drug Control Policy / Congress / MICHIGAN DEPARTMENT OF COMMUNITY HEALTH OFFICE OF DRUG CONTROL POLICY TREATMENT POLICY / Food and Drug Administration / United States House / Michigan Department of Community Health / Wayne State University / American Society of Addiction Medicine / Substance Abuse and Mental Health Services Administration / Medicare / /

Person

Chevy Chase / Donald L. Allen / Jr. / /

Position

OTP physician / qualified physician / physician / Superintendent / /

Product

naloxone / Suboxone / symptoms / Buprenorphine hydrochloride / Narcan / Subutex / naloxone hydrochloride / Suboxone® / /

ProvinceOrState

Maryland / /

SocialTag